Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse. [electronic resource]
Producer: 19910821Description: 479-82 p. digitalISSN:- 0022-3042
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine -- pharmacology
- 3,4-Dihydroxyphenylacetic Acid -- metabolism
- Animals
- Cells, Cultured
- Cerebral Ventricles -- drug effects
- Corpus Striatum -- drug effects
- Dopamine -- metabolism
- Embryo, Mammalian
- Epidermal Growth Factor -- administration & dosage
- Infusions, Parenteral
- Male
- Mesencephalon -- drug effects
- Mice
- Reference Values
- Tyrosine 3-Monooxygenase -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.